RxDoctor Payments Data

Sara McKinzie

Women's Health · Salem, ILNPI 1417371485

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 108 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 19.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,117 and has fallen 92.3% since, to $86 in 2025.

$2,001in general payments, 2019–2025

Across 108 payments — averaging $18.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$397
  • Novo Nordisk$332
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$157
  • AbbVie$151
  • GSK$122
  • Organon$115
  • plus $727 from 13 others

What the payments were for

  • Food & beverage$2,001100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,001 in reported general payments places this provider in the 85th percentile of 182 women's health providers in Illinois.

See all women's health providers in Illinois

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide20$25,110
JardianceEmpagliflozin17$17,875
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog13$4,511
Estradiol31$1,594
Potassium Chloride12$1,154
Metformin Hcl ErMetformin Hcl38$867
Gabapentin44$828
Albuterol Sulfate HfaAlbuterol Sulfate40$800
Lisinopril58$467
Pregabalin22$434
Atorvastatin Calcium50$423
Buspirone Hcl17$415
Losartan Potassium38$405
Metoprolol Succinate23$387
Rosuvastatin Calcium32$360

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$332$25,11020 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 182 women's health providers in Illinois.

Other women's health in Salem

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →